Our Researchers Among the Elsevier 2025 Top 2% Scientists

news_image

We are proud to announce that, once again this year, several researchers from our Department have been included in the prestigious Elsevier 2025 list of the Top 2% Scientists, which recognizes the most cited and influential scholars worldwide, both throughout their careers and in the past year.

This important achievement reflects the high quality of the scientific research carried out within our University, as well as the significant contribution of our researchers to advancing knowledge and innovation in the biomedical and clinical fields.

 

The following researchers from our Department have been included in the list:

  • Dr. Paolo D’Aquila – His research focuses on the role of dopamine in the mechanism of action of antidepressant drugs and in reward-related behaviors. (Career impact)
  • Prof. Angelo Zinellu – His work involves the development and application of analytical methods for studying biochemical markers associated with oxidative and inflammatory stress, using a translational approach aimed at improving the understanding of pathophysiological mechanisms and supporting clinical diagnostics. (Career and 2024 impact)
  • Prof. Gianfranco Pintus – His studies combine the analysis of redox signaling networks with the biochemistry of natural antioxidants to identify and modulate molecular pathways involved in the onset and progression of diseases. (2024 impact)
  • Prof. Leonardo Sechi – His research explores the activation of endogenous retroviruses in various neurological diseases (ALS, Multiple Sclerosis) and cancers. His group also investigates the role of a specific mycobacterium in inflammatory bowel diseases (Crohn’s disease) and autoimmune conditions (Type 1 Diabetes and Multiple Sclerosis). (2024 impact)
  • Prof. Francesco Cucca – His research focuses on diseases with a genetic component that, due to their frequency and severity, have a significant social and health impact both in Sardinia and globally. The main goal of his studies is to identify the causes and elucidate the pathogenetic mechanisms underlying these conditions, in order to discover new therapeutic targets for their treatment. (2024 impact)

The Department warmly congratulates all the researchers for this recognition and for their continuous commitment to promoting scientific excellence.